References
- Kino T., Hatanaka H., Hashimoto M., Nishiyama M., Goto T., Okuhara M., Kohsaka M., Aoki H., Imanaka H. FK506, a novel immunosupperessant isolated from a streptomyces. 1. Fermentation, isolation, and physicochemical and biological charateristics. J. Antibiotics 1987; 40: 1249–1255
- Kino T., Hatanaka H., Miyata S., Inamura N., Nishiyama M., Yajima T., Goto T., Okuhara M., Kohsaka M., Aoki H., Ochiai T. FK506, a novel immunosupperessant isolated from a streptomyces. 2. Immunosuppressive effect of FK506 in vitro. J. Antibiotics 1987; 40: 1256–1265
- Kino T., Inamura N., Sakai F., Nakahata K., Goto T., Okuhara M., Kohsaka M., Aoki H., Ochiai T. Effect of FK506 on human mixed lymphocyte reaction in vitro. Transplant. Proc. 1987; 19(suppl. 6)36–39
- Sawada S., Suzuki G., Kawase Y., Takaku F. Novel immunosuppressive agent, FK506 in vitro effects on the cloned T cell activation. J. Immunol. 1987; 139: 1797–1803
- Kay J. E., Benzie C. R., Goodier M. R., Wick C. J., Doe S. E. A. Inhibition of T‐lymphocyte activation by the immunosuppressive drug FK‐506. Immunology 1989; 67: 473–477
- Inamura N., Nakahara K., Kino T., Goto T., Aoki H., Yamaguchi I., Kohsaka M., Ochiai K. Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. Transplantation 1988; 45: 206–209
- Ochiai T., Nagata M., Nakajima K., Suzuki T., Sakamoto K., Enomoto K., Gunji Y., Uematsu T., Goto T., Hori S., Kenmochi T., Nakagouri T., Asano T., Isono K., Hamaguchi K., Tsuchida H., Nakahara K., Inamura N., Goto T. Studies of the effects of FK506 on renal allografting in the beagle dog. Transplantation 1988; 44: 729–734
- Todo S., Ueda Y., Demetris A. J., Imventaraza O., Nalesnik M., Venkataranmanan R., Makowka L., Starzl T. E. Immunosuppression of canine, monkey, and baboon allografts by FK506: with special reference to synergism with other drugs and to tolerance induction. Surgery 1988; 104: 239–249
- Thiru S., Collier D. St.J., Calne R. Pathological studies in canine and baboon renal allografts recipients immunosuppressed with FK506. Transplant. Proc. 1987; 19(suppl. 6)98–99
- Collier D. St.J., Calne R., Thiru S., Friend P. J., Lim S., White D. J. G., Kohno H., Levickis J. FK506 in experimental renal allografts in dogs and primates. Transplant. Proc. 1988; 20(suppl. 1)226–228
- Todo S., Demetris A. J., Ueda Y., Imventaraza O., Cadoff E., Zeeve A., Starzl T. E. Renal transplantation in baboons under FK506. Surgery 1989; 106: 444–451
- Starzl T. E., Todo S., Fung J., Demetris A. J., Verkataramman R., Jain A. Fk506 for liver, kidney, and pancreas transplantation. The Lancet 1989; ii: 1000–1004
- Kawashima H., Fujino Y., Mochizuki M. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveo‐retinitis in rats. Invest. Ophthalmol. Vis. Sci. 1988; 22: 1265–1271
- Takagishi K., Yamamato M., Nishimura A., Yamasaki G., Kanazawa N., Hotokebuchi T., Kaibara N. Effects of FK506 on collagen arthritis in mice. Transplant. Proc. 1988; 21(suppl. 1)1053–1055
- Inamura N., Hashimoto M., Nakahara K., Aoki H., Yamaguchi I., Kohsaka M. Immuno‐supressive effect of FK506 on collagen‐induced arthritis in rats. Clin. Immunol. Immunopathol. 1988; 46: 82–90
- Yamamoto K., Mori A., Nakahata T., Ito M., Okudaira H., Miyamoto T. Experimental treatment of autoimmune MRL‐lpr/lpr mice with immunosupressive compound FK506. Immunology 1990; 69: 222–227
- Harding M. W., Galat A., Uehling D. E., Schreiber S. L. A receptor for the immunosuppressant FK506 is a cis‐trans peptidyl‐prolyl isomerase. Nature 1989; 341: 758–760
- Siekierka J. J., Hung S. H. Y., Poe M., Lin C. S., Sigal N. H. A cytosolic binding protein for the immunosupressant FK506 has peptidyl‐prolyl isomerase activity but is distinct from cyclophilin. Nature 1989; 341: 755–757
- Nussenblatt R. B., Palestine A., Chan C. ‐C. Cyclosporine A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroid or cytotoxic agents. Am. J. Ophthalmol. 1983; 96: 275–282
- Amor B., Dougados M. Ciclosporin in rheumatoid arthritis. Open trials with different dosages. Ciclosporin in Autoimmune Diseases, R. Schindler. Springer‐Verlag, Berlin 1985; 283–287
- Nussenblatt R. B., Palestine A. Cyclosporine: immunology, phamacology and theraupeutic uses. Surv. Ophthalmol. 1986; 31: 159–169
- Nussenblatt R. B., Kuwabara T., de Monasterio F. M., Wacker W. B. S‐antigen uveitis in primates. A new model for human disease. Arch. Ophthalmol. 1981; 99: 1090–1092
- Dorey C., Cozette J., Faure J. P. A simple and rapid method for isolation of retinal S antigen. Ophthalmic Res. 1982; 14: 249–255
- Tamura K., Kobayashi M., Hashimoto K., Kojima K., Nagase K., Iwasaki K., Kaizu T., Tanaka H., Niwa M. A highly sensitive method to assay FK506 levels in plasma. Transplant. Proc. 1987; 19(suppl. 6)23–29
- Kawashima H., Mochizuki M. Effects of a new immunosupressive agent, FK506, on the effect limb of the immune responses. Exp. Eye Res. 1990; 51: 565–572
- Nussenblatt R. B., Palestine A. G. Uveitis: Fundamentals and Clinical Practice. Year Book Medical Publishers, Inc., Chicago 1989; 129
- Fujino Y., Okumura A., Nussenblatt R. B., Gery I., Mochizuki M. Cyclosporine‐induced specific unresponsiveness to retinal soluble antigen in experimental autoimmune uveoretinitis. Clin. Immunol. Immunopathol. 1988; 46: 234–248
- Imventarza O., Todo S., Eiras G., Ueda Y., Furukawa H., Wu Y. M., Zhu Y., Oks A., Demetris J., Starzl T. E. Renal transplantation in baboons under FK506. Transplant. Proc. 1990; 22(suppl. 1)64–65